155 related articles for article (PubMed ID: 30903640)
41. Allergy-driven alternative splicing of IL-13 receptor alpha2 yields distinct membrane and soluble forms.
Tabata Y; Chen W; Warrier MR; Gibson AM; Daines MO; Hershey GK
J Immunol; 2006 Dec; 177(11):7905-12. PubMed ID: 17114462
[TBL] [Abstract][Full Text] [Related]
42. Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel.
Wang B; Lv L; Wang Z; Jiang Y; Lv W; Liu X; Wang Z; Zhao Y; Xin H; Xu Q
Sci Rep; 2015 Nov; 5():16589. PubMed ID: 26567528
[TBL] [Abstract][Full Text] [Related]
43. IL-13 receptor isoforms: breaking through the complexity.
Tabata Y; Khurana Hershey GK
Curr Allergy Asthma Rep; 2007 Sep; 7(5):338-45. PubMed ID: 17697639
[TBL] [Abstract][Full Text] [Related]
44. Decreasing expression of the interleukin-13 receptor IL-13Ralpha2 in treated recurrent malignant gliomas.
Bozinov O; Kalk JM; Krayenbühl N; Woernle CM; Sure U; Bertalanffy H
Neurol Med Chir (Tokyo); 2010; 50(8):617-21. PubMed ID: 20805641
[TBL] [Abstract][Full Text] [Related]
45. Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2.
Rahaman SO; Vogelbaum MA; Haque SJ
Cancer Res; 2005 Apr; 65(7):2956-63. PubMed ID: 15805299
[TBL] [Abstract][Full Text] [Related]
46. Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy.
Saikali S; Avril T; Collet B; Hamlat A; Bansard JY; Drenou B; Guegan Y; Quillien V
J Neurooncol; 2007 Jan; 81(2):139-48. PubMed ID: 17004103
[TBL] [Abstract][Full Text] [Related]
47.
He CH; Lee CG; Ma B; Kamle S; Choi AMK; Elias JA
Am J Respir Cell Mol Biol; 2020 Sep; 63(3):386-395. PubMed ID: 32402213
[TBL] [Abstract][Full Text] [Related]
48. Cloning of the chicken interleukin-13 receptor alpha 2 gene and production of a specific monoclonal antibody.
Miyoshi M; Horiuchi H; Fukushima Y; Matsuda H; Furusawa S
Dev Comp Immunol; 2007; 31(4):394-406. PubMed ID: 16926048
[TBL] [Abstract][Full Text] [Related]
49. Semaphorin 3A lytic hybrid peptide binding to neuropilin-1 as a novel anti-cancer agent in pancreatic cancer.
Ueyama H; Horibe T; Nakajima O; Ohara K; Kohno M; Kawakami K
Biochem Biophys Res Commun; 2011 Oct; 414(1):60-6. PubMed ID: 21945444
[TBL] [Abstract][Full Text] [Related]
50. Identification of interleukin-13 receptor alpha2 peptide analogues capable of inducing improved antiglioma CTL responses.
Eguchi J; Hatano M; Nishimura F; Zhu X; Dusak JE; Sato H; Pollack IF; Storkus WJ; Okada H
Cancer Res; 2006 Jun; 66(11):5883-91. PubMed ID: 16740728
[TBL] [Abstract][Full Text] [Related]
51. Potent anti-tumor effects of EGFR-targeted hybrid peptide on mice bearing liver metastases.
Gaowa A; Horibe T; Kohno M; Harada H; Hiraoka M; Kawakami K
Clin Exp Metastasis; 2016 Jan; 33(1):87-95. PubMed ID: 26467564
[TBL] [Abstract][Full Text] [Related]
52. Killing effect of interleukin-13 receptor alpha 2 (IL-13Ralpha2) sensitized DC-CTL cells on human glioblastoma U251 cells.
Yan X; Su Z; Zhang J; Wu Z; Ye S; Lu X; Wu J; Zeng Y; Zheng W
Cell Immunol; 2010; 263(2):172-5. PubMed ID: 20400066
[TBL] [Abstract][Full Text] [Related]
53. Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy.
Lai EW; Joshi BH; Martiniova L; Dogra R; Fujisawa T; Leland P; de Krijger RR; Lubensky IA; Elkahloun AG; Morris JC; Puri RK; Pacak K
J Clin Endocrinol Metab; 2009 Aug; 94(8):2952-7. PubMed ID: 19491224
[TBL] [Abstract][Full Text] [Related]
54. Anti-tumor effects of progesterone in human glioblastoma multiforme: role of PI3K/Akt/mTOR signaling.
Atif F; Yousuf S; Stein DG
J Steroid Biochem Mol Biol; 2015 Feb; 146():62-73. PubMed ID: 24787660
[TBL] [Abstract][Full Text] [Related]
55. Screening a novel FGF3 antagonist peptide with anti-tumor effects on breast cancer from a phage display library.
Wang W; Chen T; Li H; Chen Y; Wu Z; Feng T; Zhang X; Zhong Q; Zhong Q; Li G; Guo L; Zhou L; Zhou J
Mol Med Rep; 2015 Nov; 12(5):7051-8. PubMed ID: 26323695
[TBL] [Abstract][Full Text] [Related]
56. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of IL-13 and IL-13Rα2 Expression by IL-32θ in Human Monocytic Cells Requires PKCδ and STAT3 Association.
Pham TH; Bak Y; Oh JW; Hong J; Lee S; Hong JT; Yoon DY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010051
[TBL] [Abstract][Full Text] [Related]
58. Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma.
Ishida CT; Zhang Y; Bianchetti E; Shu C; Nguyen TTT; Kleiner G; Sanchez-Quintero MJ; Quinzii CM; Westhoff MA; Karpel-Massler G; Prabhu VV; Allen JE; Siegelin MD
Clin Cancer Res; 2018 Nov; 24(21):5392-5406. PubMed ID: 30037819
[No Abstract] [Full Text] [Related]
59. Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes.
Ulzii D; Kido-Nakahara M; Nakahara T; Tsuji G; Furue K; Hashimoto-Hachiya A; Furue M
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284553
[TBL] [Abstract][Full Text] [Related]
60. A small molecule targeting CHI3L1 inhibits lung metastasis by blocking IL-13Rα2-mediated JNK-AP-1 signals.
Lee YS; Yu JE; Kim KC; Lee DH; Son DJ; Lee HP; Jung JK; Kim ND; Ham YW; Yun J; Han SB; Hong JT
Mol Oncol; 2022 Jan; 16(2):508-526. PubMed ID: 34758182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
